Torrent Pharmaceuticals accepts resignation of Executive Director Amal Kelshikar
- Amal Kelshikar resigned as Executive Director of Torrent Pharmaceuticals
- Resignation effective October 16, 2026, at close of business hours
- Filing made under Regulation 30 of SEBI Listing Regulations
- Kelshikar served beyond superannuation before transitioning out
*this image is generated using AI for illustrative purposes only.
Torrent Pharmaceuticals Limited accepted the resignation of Amal Kelshikar, Executive Director and Senior Management Personnel (SMP), effective from the close of business hours on October 16, 2026.
The company informed BSE and NSE under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure referenced SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, regarding changes in senior management.
Resignation details
Kelshikar formally submitted his resignation letter to the Managing Director, Aman Torrent. In the letter, he cited a desire to transition after thoughtful reflection, noting that while it was a difficult step, he believed it was the right time. He expressed gratitude for the support and trust extended during his association with the company, specifically mentioning his extended tenure beyond superannuation.
The resignation was accepted by Chintan M Trivedi, Company Secretary, who signed the intimation digitally on October 16, 2026, at 5:54 pm IST.
Key personnel information
The following table summarizes the key details disclosed in the regulatory filing:
| Detail | Information |
|---|---|
| Name | Amal Kelshikar |
| Designation | Executive Director |
| Reason for change | Resignation |
| Effective date | October 16, 2026 |
| Status | Cessation from post |
Kelshikar stated his commitment to supporting a smooth transition and completing all handover formalities. No new appointment or interim arrangement was disclosed in this specific filing.
Historical Stock Returns for Torrent Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.55% | -1.26% | -6.00% | +9.61% | +29.04% | 0.0% |
Who will be appointed as the successor to Amal Kelshikar, and what is the expected timeline for this appointment?
How might Kelshikar's departure impact Torrent Pharmaceuticals' ongoing strategic initiatives and R&D pipeline execution?
Will the leadership transition affect Torrent Pharmaceuticals' stock price volatility or investor confidence in the near term?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
